Drei Wissenschaftler der Universität Basel haben sich erfolgreich um einen Starting Grant des Europäischen Forschungsrats (ERC) beworben: Der Biomediziner Dr. Nicola Aceto, der Mathematiker Prof. Gianluca Crippa und der Physiker Prof. Philipp Treutlein erhalten in den kommenden fünf Jahren Fördermittel von bis zu 1,7 Millionen Euro.Three researchers from the University of Basel have successfully applied for a starting grant of the European Research Council (ERC): Biomedical specialist Dr. Nicola Aceto, mathematician Professor Gianluca Crippa and physicist Professor Philipp Treutlein will receive funding of up to 1.7 million Euros over the next five years.
Researchers at the University of Basel took a close look at a signaling pathway present in most organisms and found that it suppresses the formation of specific types of brain tumor.
Mice that spent time running on wheels developed twice the normal number of new brain cells and increased their ability to distinguish new objects from familiar objects compared to inactive mice, reports a new study by researcher of the University of Basel.
Today, Friday, November 27 2015, the University of Basel celebrated its Dies Academicus with a traditional ceremony in Basel’s St. Martin’s Church. Seven individuals were awarded honorary doctorates during the ceremony.
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years. Researchers from the University and University Hospital Basel have now for the first time successfully combined such an antibody-drug conjugate with a therapy that stimulates the immune system to attack tumor cells.
With an amount totalling 14 million Swiss francs, the Eckenstein-Geigy Foundation is sponsoring a new professorship in Epidemiology and Household Economics. The professorship at the University of Basel will be based at the Swiss Tropical and Public Health Institute (Swiss TPH).
The BK polyomavirus often causes complications after kidney transplantation. A research group from the Department of Biomedicine at the University and the University Hospital of Basel has now been able to show, that the immunosuppressive drug Tacrolimus directly activates the replication of the virus and could thus be responsible for these complications.
The startup company “T3 Pharmaceuticals” at the Biozentrum of the University of Basel has developed a fast and simple tool to selectively inject diverse proteins into cells.
Scientists from the Swiss Nanoscience Institute and the Department of Physics at the University of Basel have demonstrated for the first time how electrons are transported from a superconductor through a quantum dot into a metal with normal conductivity.